Expert insights. Personalized for you.
Clinical DevelopmentResults from the research indicate use of ACE in inhibitors and ARBs could prove useful in treating COVID-19 patients of African-American descent. MORE
Trial design and other details are being evaluated and a comprehensive update on the overall Novartis SMA clinical development program will be provided at a future time following further discussions with health authorities. MORE
The company is delving into clinical research partnerships geared toward saving the lives of soldiers, eventually translating findings to civilian care. Clinical Development MORE
Press Release 30 September 2020 Immunicum AB Announces Update on Corporate and Clinical Development Strategy Immunicum AB (publ: IMMU.ST) announced today an update on the Company’s corporate and clinical development strategy. The strategy will be presented by members of the … Continue reading → GlobeNewswire MORE
Clinical-stage biopharmaceutical firm ESCAPE Bio has snagged a $73 million crossover financing deal, led by Wellington Management Company, which will help advance the company’s two clinical development programs of precision neurology medicines for patients with genetic neurodegeneration MORE
Novartis Gene Therapies to initiate new pivotal confirmatory study to evaluate use of AVXS-101 intrathecal (IT) formulation in older patients with SMA to further support registration Basel, September 23, 2020 – Novartis Gene Therapies recently received feedback from the US … Continue reading → GlobeNewswire MORE
The clinical-stage drug development company has kicked off testing the experimental anticancer drug Veyonda on severe patients in a Phase I trial. Clinical Development MORE
Clinical DevelopmentAmerican Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC. MORE
– Detailed characterization of an oral inhibitor of CDK7 demonstrates potent activity against multiple hematologic and solid tumor cell lines, as monotherapy and in combination with chemotherapies – ALAMEDA, Calif.–(BUSINESS –(BUSINESS WIRE)–Exelixis, Inc. MORE
Nanobiotix global development plan for first-in-class radioenhancer NBTXR3 across several solid tumor indications proceeds as planned with focus on priority pathways in head and neck cancer and immunotherapy Data from the expansion part of the phase I study in head … Continue reading → Business Wire MORE
The clinical research site network has tapped 22-year industry veteran Karri Venn, president of research with LMC Manna, to lead the organization. Clinical Development MORE
A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going. Clinical Development MORE
The CRO will work with the Leukemia and Lymphoma Society on a global master clinical trial to explore treatments for pediatric acute leukemia. Clinical Development MORE
and Shionogi Limited as shareholders, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical development programme. Clinical Trails MORE
Clinical DevelopmentA leader from a New Zealand-based CRO talks about the countryâs handling of the pandemic, and how their low rates are making sponsors take notice. MORE
GHENT, Belgium–(BUSINESS WIRE)–Confo Therapeutics today announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to address peripheral neuropathic pain with the potential to address additional pain indications. MORE
The CRO and life-sciences tech firm collaborated on a solution capable of meeting challenges tied to starting and conducting global clinical trials. Clinical Development MORE
Clinical DevelopmentThe companyâs studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe. MORE
The clinical-stage biotech firm is investigating early efficacy of its Cymerus mesenchymal stem cells for treatment of severe COVID-19 patients. Clinical Development MORE
eClinical, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products. Clinical Development MORE
Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials. Clinical Development MORE
The health solutions firm is looking to remote patient monitoring to overcome significant clinical trial obstacles created by the ongoing pandemic. Clinical Development MORE
Clinical DevelopmentThe agencyâs Solidarity Therapeutics Trial examined a range of drugs repurposed for COVID-19 treatment, finding nearly no effect on patient mortality. MORE
Clinical DevelopmentThe companyâs Phase II trial of ultramicronized PEA has received FDA approval and expects to begin dosing patientparticipants as early as next month. MORE
Clinical DevelopmentLed by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemicâs effects. MORE
Clinical DevelopmentThe company has expanded the footprint of the location to accommodate an anticipated increase in the need for COVID-19 vaccine and storage needs. MORE
million 100% funding for development, manufacturing and commercial registration of Ii-Key- … Continue reading → GlobeNewswireBintai Kinden Corporation Berhad (www.bintai.com.my) is an investment holding company headquartered in Malaysia with operations throughout South-East Asia, China, and the Arabian Gulf Region Upfront licensing fee of $2.5 MORE
TPG Capital establishes new entity to continue the development of select clinical assets spun-out of Adare Pharmaceuticals Announcement follows TPG Capital’s sale of Adare Pharmaceuticals’ specialty CDMO pharmaceutical technology and microbiome businesses SAN FRANCISCO & FORT WORTH, Texas–(BUSINESS WIRE)–TPG Capital, … Continue reading → Business Wire MORE
The cloud-based study technology firm has secured Series B funding to help develop and promote products like its clinical trial platform, StudyTeam. Clinical Development MORE
Clinical DevelopmentA veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short. MORE
Clinical DevelopmentThe precision study at the center of the partnership is geared toward identifying novel synergies across a broad variety of anticancer therapies. MORE
Clinical DevelopmentExperts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week. MORE
Clinical DevelopmentNeurotrope has kicked off its ongoing Phase II study of Bryostatin-1 for treatment of Alzheimerâs disease, with the help of a $2.7m NIH grant. MORE
The US agency has launched a large clinical trial to examine the viability of using immune modulators to treat patients hospitalized with COVID-19. Clinical Development MORE
An online patient community specializing in rare diseases has launched Xperiome, a knowledge platform aimed at speeding development of treatments. Clinical Development MORE
LONDON & CHICAGO–(BUSINESS WIRE)–#advisoryboard–Anova Enterprises, Inc. MORE
A representative from the pharma services firm discusses how increasing diversity of clinical trial populations can improve research effectiveness. Clinical Development MORE
Clinical DevelopmentIn a Phase III trial, Farxiga reportedly showed reduction in the risk of kidney failure, and cardiovascular (CV) or renal death, in CKD patients. MORE
Clinical DevelopmentThe AI platform combines machine-learning models and advanced semantic technologies to help life-science users gain insights from their data. MORE
Clinical DevelopmentThe collaboration will target signs of early deterioration in patients, and predict infection severity to let caregivers know when to escalate care. MORE
blends behavioral science, decision economics and technology to better integrate the patient voice into clinical research. Clinical DevelopmentStudy solutions provider H? MORE
Clinical Development Related Topics BioTech 365
SEPTEMBER 30, 2020
Press Release 30 September 2020 Immunicum AB Announces Update on Corporate and Clinical Development Strategy Immunicum AB (publ: IMMU.ST) announced today an update on the Company’s corporate and clinical development strategy. The strategy will be presented by members of the … Continue reading → GlobeNewswire
BioSpace
SEPTEMBER 14, 2020
Clinical-stage biopharmaceutical firm ESCAPE Bio has snagged a $73 million crossover financing deal, led by Wellington Management Company, which will help advance the company’s two clinical development programs of precision neurology medicines for patients with genetic neurodegeneration
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
SEPTEMBER 22, 2020
Trial design and other details are being evaluated and a comprehensive update on the overall Novartis SMA clinical development program will be provided at a future time following further discussions with health authorities.
BioTech 365
SEPTEMBER 23, 2020
Novartis Gene Therapies to initiate new pivotal confirmatory study to evaluate use of AVXS-101 intrathecal (IT) formulation in older patients with SMA to further support registration Basel, September 23, 2020 – Novartis Gene Therapies recently received feedback from the US … Continue reading → GlobeNewswire
BioTech 365
OCTOBER 15, 2020
GHENT, Belgium–(BUSINESS WIRE)–Confo Therapeutics today announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to address peripheral neuropathic pain with the potential to address additional pain indications.
Outsourcing Pharma
OCTOBER 19, 2020
Clinical DevelopmentThe agencyâs Solidarity Therapeutics Trial examined a range of drugs repurposed for COVID-19 treatment, finding nearly no effect on patient mortality.
The Pharma Data
OCTOBER 21, 2020
and Shionogi Limited as shareholders, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical development programme. Clinical Trails
BioTech 365
OCTOBER 7, 2020
LONDON & CHICAGO–(BUSINESS WIRE)–#advisoryboard–Anova Enterprises, Inc.
Outsourcing Pharma
OCTOBER 8, 2020
Clinical DevelopmentA veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short.
BioTech 365
SEPTEMBER 22, 2020
TPG Capital establishes new entity to continue the development of select clinical assets spun-out of Adare Pharmaceuticals Announcement follows TPG Capital’s sale of Adare Pharmaceuticals’ specialty CDMO pharmaceutical technology and microbiome businesses SAN FRANCISCO & FORT WORTH, Texas–(BUSINESS WIRE)–TPG Capital, … Continue reading → Business Wire
Outsourcing Pharma
SEPTEMBER 30, 2020
Clinical DevelopmentThe companyâs Phase II trial of ultramicronized PEA has received FDA approval and expects to begin dosing patientparticipants as early as next month.
Outsourcing Pharma
OCTOBER 20, 2020
Clinical DevelopmentA leader from a New Zealand-based CRO talks about the countryâs handling of the pandemic, and how their low rates are making sponsors take notice.
Outsourcing Pharma
AUGUST 11, 2020
Clinical DevelopmentAmerican Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.
Outsourcing Pharma
AUGUST 24, 2020
Clinical DevelopmentLed by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemicâs effects.
BioTech 365
OCTOBER 9, 2020
– Detailed characterization of an oral inhibitor of CDK7 demonstrates potent activity against multiple hematologic and solid tumor cell lines, as monotherapy and in combination with chemotherapies – ALAMEDA, Calif.–(BUSINESS –(BUSINESS WIRE)–Exelixis, Inc.
Outsourcing Pharma
AUGUST 10, 2020
Clinical DevelopmentExperts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week.
Outsourcing Pharma
JULY 30, 2020
A representative from the pharma services firm discusses how increasing diversity of clinical trial populations can improve research effectiveness. Clinical Development
Outsourcing Pharma
OCTOBER 13, 2020
The clinical-stage drug development company has kicked off testing the experimental anticancer drug Veyonda on severe patients in a Phase I trial. Clinical Development
Outsourcing Pharma
OCTOBER 19, 2020
The CRO and life-sciences tech firm collaborated on a solution capable of meeting challenges tied to starting and conducting global clinical trials. Clinical Development
Outsourcing Pharma
OCTOBER 6, 2020
Clinical DevelopmentNeurotrope has kicked off its ongoing Phase II study of Bryostatin-1 for treatment of Alzheimerâs disease, with the help of a $2.7m NIH grant.
Outsourcing Pharma
AUGUST 19, 2020
Clinical DevelopmentThe precision study at the center of the partnership is geared toward identifying novel synergies across a broad variety of anticancer therapies.
Outsourcing Pharma
OCTOBER 22, 2020
Clinical DevelopmentThe collaboration will target signs of early deterioration in patients, and predict infection severity to let caregivers know when to escalate care.
Outsourcing Pharma
OCTOBER 5, 2020
Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials. Clinical Development
Outsourcing Pharma
OCTOBER 21, 2020
The US agency has launched a large clinical trial to examine the viability of using immune modulators to treat patients hospitalized with COVID-19. Clinical Development
Outsourcing Pharma
SEPTEMBER 9, 2020
The clinical-stage biotech firm is investigating early efficacy of its Cymerus mesenchymal stem cells for treatment of severe COVID-19 patients. Clinical Development
Outsourcing Pharma
AUGUST 18, 2020
A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going. Clinical Development
Outsourcing Pharma
OCTOBER 12, 2020
blends behavioral science, decision economics and technology to better integrate the patient voice into clinical research. Clinical DevelopmentStudy solutions provider H?
Outsourcing Pharma
OCTOBER 8, 2020
eClinical, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products. Clinical Development
Outsourcing Pharma
SEPTEMBER 10, 2020
The company is delving into clinical research partnerships geared toward saving the lives of soldiers, eventually translating findings to civilian care. Clinical Development
BioPharma Reporter
SEPTEMBER 29, 2020
Clinical DevelopmentThe companyâs studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe.
Outsourcing Pharma
JULY 22, 2020
Clinical DevelopmentThe company has expanded the footprint of the location to accommodate an anticipated increase in the need for COVID-19 vaccine and storage needs.
Outsourcing Pharma
AUGUST 19, 2020
An online patient community specializing in rare diseases has launched Xperiome, a knowledge platform aimed at speeding development of treatments. Clinical Development
Outsourcing Pharma
SEPTEMBER 22, 2020
The CRO will work with the Leukemia and Lymphoma Society on a global master clinical trial to explore treatments for pediatric acute leukemia. Clinical Development
Outsourcing Pharma
OCTOBER 13, 2020
The clinical research site network has tapped 22-year industry veteran Karri Venn, president of research with LMC Manna, to lead the organization. Clinical Development
Outsourcing Pharma
SEPTEMBER 28, 2020
Clinical DevelopmentResults from the research indicate use of ACE in inhibitors and ARBs could prove useful in treating COVID-19 patients of African-American descent.
BioTech 365
SEPTEMBER 18, 2020
million 100% funding for development, manufacturing and commercial registration of Ii-Key- … Continue reading → GlobeNewswireBintai Kinden Corporation Berhad (www.bintai.com.my) is an investment holding company headquartered in Malaysia with operations throughout South-East Asia, China, and the Arabian Gulf Region Upfront licensing fee of $2.5
BioPharma Reporter
SEPTEMBER 15, 2020
Clinical DevelopmentIn a Phase III trial, Farxiga reportedly showed reduction in the risk of kidney failure, and cardiovascular (CV) or renal death, in CKD patients.
Outsourcing Pharma
AUGUST 13, 2020
The cloud-based study technology firm has secured Series B funding to help develop and promote products like its clinical trial platform, StudyTeam. Clinical Development
Outsourcing Pharma
SEPTEMBER 24, 2020
Clinical DevelopmentThe AI platform combines machine-learning models and advanced semantic technologies to help life-science users gain insights from their data.
Outsourcing Pharma
SEPTEMBER 30, 2020
The health solutions firm is looking to remote patient monitoring to overcome significant clinical trial obstacles created by the ongoing pandemic. Clinical Development
56 
Let's personalize your content